QPI-1017

N/A

Report date: 2022/01/29 14:52:46
NME

Base Information

Drug NameQPI-1017
Drug Alias NameQPI-1017
ClassificationOther
Mechanisms of ActionRNA interferenceCaspase-2 inhibitors
TargetsCaspase-2
Therapy Area/IndicationsGlaucoma, Open-AngleMeniere Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuark Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleMeniere Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A